跳至主要内容
临床试验/NCT05416983
NCT05416983已完成不适用

The Development of a Shared Decision-Making Encounter Tool for Decisions of Adjuvant Treatment in Patients With Resected Non-Small Cell Lung Cancer

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2022年2月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
37
试验地点
1
主要终点
Development of decision aid

研究概览

简要总结

This study observes conversations between non-small cell lung cancer patients and their doctors to support the development of a decision aid that can be used to inform discussions about treatment options for after surgery. Patients who have undergone surgery for their non-small cell lung cancer may have the option of completing additional treatment. Patients contemplating this additional treatment have been shown to be most satisfied with their choice if they perceive an effort by their doctor to share decision making. Shared decision making tools can help doctors guide conversations, offer tailored recommendations, and support deliberation on whether or not to pursue treatment. This study develops a shared decision making tool for patients with surgically removed non-small cell lung cancer contemplating additional treatment.

详细描述

PRIMARY OBJECTIVE:

I. To develop, in close collaboration with stakeholders, an evidence-based decision aid to inform discussions regarding options for adjuvant treatment in patients with resected non-small cell lung cancer (NSCL) (NSCL adjuvant choice).

OUTLINE:

Patient and clinician discussions are observed to support refinement of a decision aid. Clinicians may use a prototype of the decision aid in discussions with their patients and may complete a questionnaire.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • PATIENTS:
  • Adults >= 18 years with biopsy proven resected non-small cell lung cancer (NSCLC)
  • Appointments to discuss adjuvant treatment of resected NSCLC
  • CLINICIANS:
  • Clinicians who meet with patients to discuss adjuvant treatment of resected NSCLC
  • PAG MEMBERS:
  • Adults >= 18 years
  • Member of the Knowledge and Evaluation Research (KER) Unit Patient Advisory Group (PAG)

排除标准

  • Major barriers to providing informed consent (i.e., dementia, severe hearing or visual impairment)

结局指标

主要结局

Development of decision aid

时间窗: Up to study completion, up to 2 years

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验